If the president insists that federal agencies buy domestically made essential drugs, those agencies should guarantee higher prices and sales volume in long-term contracts with drug makers, and the government should give generic drug makers tax breaks and grants because other countries lured away production with similar incentives, Association for Accessible Medicines Interim CEO Jeff Francer said Thursday (Aug. 6). Trump on Thursday signed an executive order that directs government agencies to buy drugs and medical equipment made in the...